Nouf Alanazi
Overview
Explore the profile of Nouf Alanazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Shaibi K, Alasnag M, AlShemmari O, AlSaleh A, AlKashkari W, AlMutairi F, et al.
J Saudi Heart Assoc
. 2024 Oct;
36(2):158-173.
PMID: 39469524
Objectives: We aimed to develop a streamlined algorithm for the management of intracoronary calcification that includes guidance on intracoronary imaging and the appropriate selection of atherectomy devices. Methods: National experts...
2.
Alasnag M, Alanazi N, Al-Shaikh S, Almerri K, Almoghairi A, Alenezi A, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(6):100509.
PMID: 39132359
Background: Several international registries have examined outcomes in women undergoing transcatheter aortic valve replacement (TAVR). However, none of these studies included women from the Gulf region. The Women IN Gulf...
3.
Alanazi N, Gu F, Li C, Lorenz R, Hong C
Oncol Nurs Forum
. 2024 Mar;
51(2):163-174.
PMID: 38442284
Objectives: To examine sleep quality and self-reported causes of sleep disturbance among patients with breast cancer at diagnosis and one year later. Sample & Setting: 486 of 606 patients with...
4.
Alshora D, Ibrahim M, Alanazi N, Alowyid M, Ali Alnakhli Z, Alshiban N, et al.
Saudi Pharm J
. 2023 Nov;
31(12):101830.
PMID: 38028219
Glibenclamide (GB), oral antidiabetic sulfonylurea, is used in the management of diabetes mellitus type II. It suffers from low bioavailability due to low water solubility. This work aimed to enhance...
5.
Alasnag M, Bokhari F, Almoghairi A, Marri K, Alenezi A, Alharbi W, et al.
BMJ Open
. 2023 Sep;
13(9):e073549.
PMID: 37730395
Background: Severe mitral regurgitation (MR) with left ventricular dysfunction portends worse outcomes. Over the course of the last two decades, transcatheter repair of the mitral valve offered an alternative therapeutic...
6.
Alasnag M, Almerri K, Almoghairi A, Alenezi A, Bardooli F, Al-Sheikh S, et al.
Cardiovasc Revasc Med
. 2022 Jan;
41:19-26.
PMID: 35033460
Background: The use of transcatheter aortic valve replacement (TAVR) is steadily increasing with TAVR procedures offered to patients across the entire spectrum of surgical risks. The Gulf TAVR registry captures...
7.
Alharbi M, Alanazi N, Yousef A, Alanazi N, Alotaibi B, Aljurf M, et al.
Expert Rev Hematol
. 2022 Jan;
15(2):157-166.
PMID: 35025706
Background: Immune thrombocytopenia, also known as immune thrombocytopenic purpura (ITP), has emerged as a significant COVID-19-associated complication. This study analyzes the published literature of case reports and case series regarding...
8.
9.
Omair M, Alhawassi T, Alwaihibi M, Aldrees G, Mosli M, Asser W, et al.
Saudi Pharm J
. 2021 Jan;
28(12):1827-1829.
PMID: 33424270
The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness...
10.
AlRuthia Y, Alhazzani H, Alhindi G, Alarfaj M, Almutairi L, Alanazi M, et al.
J Pain Res
. 2020 Nov;
13:2929-2936.
PMID: 33235491
Background: Musculoskeletal pain is one of the most complex and debilitating types of pain. Although different pharmacologic treatments are available, very few studies have explored the predictors for opioid analgesics...